Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Amphotericin B 100mg tablets
0502030A0AAACAC
|
Amphotericin (Systemic) | Amphotericin | Infections | No data available |
|
Amphotericin B 100mg/ml oral solution
0502030A0AAANAN
|
Amphotericin (Systemic) | Amphotericin | Infections | No data available |
|
Amphotericin B 100mg/ml oral suspension sugar free
0502030A0AAABAB
|
Amphotericin (Systemic) | Amphotericin | Infections | No data available |
|
Amphotericin B 50mg powder for solution for infusion vials
0502030A0AAAAAA
|
Amphotericin (Systemic) | Amphotericin | Infections | No data available |
|
Amphotericin B liposomal 50mg pdr for dispersion for inf vl
0502030A0AAAIAI
|
Amphotericin (Systemic) | Amphotericin | Infections | No data available |
|
Amphotericin B sod cholesteryl sulf complex 100mg inf vials
0502030A0AAAMAM
|
Amphotericin (Systemic) | Amphotericin | Infections | No data available |
|
Amphotericin B sod cholesteryl sulf complex 50mg inf vials
0502030A0AAAJAJ
|
Amphotericin (Systemic) | Amphotericin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.